From: Psychometric properties of the EORTC QLQ-C30 in Uganda
Ā | Total n (%) | Luganda n (%) | English n (%) | Ļ2b | Df | P value |
---|---|---|---|---|---|---|
Sample size | 385 (100) | 217 (100) | 168 (100) | Ā | Ā | Ā |
Clinical setting | Ā | Ā | Ā | 0.39 | 1 | 0.533 |
In Patient | 257 (66.8) | 142 (65.4) | 115 (68.5) | Ā | Ā | Ā |
Out Patient | 128 (33.2) | 75 (34.6) | 53 (31.5) | Ā | Ā | Ā |
Cancer type | Ā | Ā | Ā | 11.61 | 9 | 0.236 |
Cervical | 92 (23.9) | 60 (27.6) | 32 (19.0) | Ā | Ā | Ā |
Breast | 68 (17.7) | 32 (14.7) | 36 (21.4) | Ā | Ā | Ā |
KS | 43 (11.2) | 28 (12.9) | 15 (8.9) | Ā | Ā | Ā |
Leukemia | 26 (6.7) | 14 (6.5) | 12 (7.1) | Ā | Ā | Ā |
Prostate | 22 (5.7) | 12 (5.5) | 10 (6.0) | Ā | Ā | Ā |
Oesophageal | 20 (5.2) | 8 (3.7) | 12 (7.1) | Ā | Ā | Ā |
Lymphoma | 18 (4.7) | 7 (3.2) | 11 (6.5) | Ā | Ā | Ā |
Lung | 8 (2.1) | 5 (2.3) | 3 (1.8) | Ā | Ā | Ā |
Ovarian | 8 (2.1) | 4 (1.8) | 4 (2.4) | Ā | Ā | Ā |
Other | 80 (20.8) | 47 (21.7) | 33 (19.6) | Ā | Ā | Ā |
Cancer Stage | Ā | Ā | Ā | 1.39 | 1 | 0.499 |
Early (I & II) | 99 (25.7) | 51 (23.5) | 48 (28.6) | Ā | Ā | Ā |
Late (III & IV) | 208 (54) | 122 (56.2) | 86 (51.2) | Ā | Ā | Ā |
Not reporteda | 78 (20.3) | 44 (20.3) | 34 (20.3) | Ā | Ā | Ā |
Type of treatment | Ā | Ā | Ā | 0.02 | 1 | 0.813 |
Chemotherapy | 235 (61) | 130 (59.9) | 105 (62.5) | Ā | Ā | Ā |
Radiotherapy | 94 (24.4) | 51 (23.5) | 43 (25.6) | Ā | Ā | Ā |
Surgery | 38 (9.9) | 21 (9.7) | 17 (10.1) | Ā | Ā | Ā |
Palliative | 15 (3.9) | 12 (5.5) | 3 (1.8) | Ā | Ā | Ā |
No treatment yet | 3 (<ā1) | 3 (<ā1) | ā | Ā | Ā | Ā |
Grouped KPS | Ā | Ā | Ā | 0.41 | 2 | 0.813 |
āā¤ā40 | 58 (15.1) | 34 (15.7) | 24 (14.3) | Ā | Ā | Ā |
50ā70 | 162(42.1) | 93 (42.9) | 69 (41.1) | Ā | Ā | Ā |
āā„ā80 | 165 (42.9) | 90 (41.5) | 75 (44.6) | Ā | Ā | Ā |